S.E.A. Medical Secures $3 Million in Series B Financing from JK&B Capital
Healthtech company makes strides towards developing medical devices designed to catch life-threatening IV drug errors before they harm patients
Healthtech company makes strides towards developing medical devices designed to catch life-threatening IV drug errors before they harm patients
S.E.A. Medical Systems, Inc. is developing solutions for making intravenous (IV) drug delivery safer for patients.
S.E.A. Medical Systems, Inc., a privately held medical device company dedicated to making intravenous drug delivery safer for patients, recently welcomed two additions to their Board of Directors.
“The Provider as a System” will discuss how innovations in information management and technology coupled with changes in the business landscape are transforming the delivery of healthcare.
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
A recent study commissioned by the Society of Actuaries and completed by Milliman, Inc., highlighted both the high personal and financial costs exacted by measurable medical errors.
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
Medication error is one of the top 10 causes of death in the United States, killing an estimated 7,000 people per year.
Intravenous (IV) drugs leave a huge margin for human error, particularly at the point of administration.
Copyright © 2024 | WordPress Theme by MH Themes